摘要:
An implant, usually a stent, has a coating of a cross-linked water swellable polymer matrix preferably having a dry thickness of at least 0.1 νm, and a pharmaceutically active compound, the polymer having pendant cationic and pendant zwitterionic groups. The active is usually an anionic compound such as a nucleic acid. The polymer is peferably formed from 2-methacyloyloxyethyl-2'-trimethylammoniumethyl phosphate inner salt, trialkylammoniumalkyl(meth)acrylate and a cross-linkable monomer such as φ-(trialkoxysilyl)alkyl(meth)acrylate, optionally with a termonomer such as a higher alkyl (meth)acrylate. The stent is coated with polymer, cross-linked then contacted with a solution or dispersion of active compound in a solvent which swells the polymer wehereby the active is absorbed into the polymer matrix. The stent is delivered by usual means into a body lumen and the active is released over an extended period of time into the wall of the lumen and/or fluid flowing therein.
摘要:
A polymer blend for use in a biomedical application comprising: (A) a polymer A, bearing zwitterionic pendant groups; and (B) a hydrophobic addition polymer B, selected from the group consisting silyl(alk)acrylates, alkyl(alk)acrylamides, dialkyl(alk)acrylamides, and alkyl(alk)acrylate polymers, wherein the structure of the blend exhibits phase separation forming a micro-phase segregated structure at a surface. Articles, methods of production and liquid blend compositions are also disclosed. Preferably A is a copolymer of 15 to 30 mole % 2-methacryloyloxyethyl-2'-trimethylammonium ethyl phosphate inner salt and 85 to 70 mole % of a C6-18 alkyl methacrylate, and B is a homopolymer of a C4-18 alkyl(meth)acrylate, blended in weight proportions of 1:1 to 1:50.
摘要:
Aérosol comprenant un fluide porteur et des liposomes en suspension dans ledit fluide et contenant un phospholipide, un agent thérapeutique ou diagnostique destinés à être inhalés étant enfermés dans lesdits liposomes.
摘要:
A silicon containing adduct having the formula (I) wherein X is an electron withdrawing group selected from the group consisting of carbonyl and sulphone groups, sulphonium and phosphonium salts; R is selected from the group consisting of hydrogen, linear and branched alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl, aralkyl, alkoxyaryl, alkoxyalkyl, oligoalkoxyalkyl, di-alkylaminoalkyl, N-aryl-N-alkylaminoalkyl, hydroxyalkoxy, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy, cycloalkenyloxy, cycloalkynyloxy, aralkoxy, alkoxyaryloxy, alkoxyalkoxy, oligoalkoxyalkoxy, di-alkylaminoalkoxy, N-aryl-N-alkylamino-alkoxy, acyloxy, acyloxyalkyl, N-diacyl-iminoalkyl groups, organosilane, organosiloxane, hydroxyaryl, hydroxyalkenyl, hydroxyalkynyl and hydroxy groups and any of the above groups substituted with one or more hydroxyl or zwitterionic group Z, or R-X- is a nitrile group; R?3 and R4¿ are individually selected from the group consisting of hydrogen, linear and branched alkyl, alkenyl, and alkynyl groups, aryl, alkoxycarbonyl, alkylaminocarbonyl, cycloalkyl, cycloalkenyl, cycloalkynyl, haloaryl, haloalkyl, alkaryl, aralkyl, alkoxyaryl, alkoxyalkyl, oligoalkoxyalkyl, aminoalkyl, mono- and di-alkylaminoalkyl, arylaminoalkyl, N-aryl-N-alkylaminoalkyl and -aminoaryl, acyloxy, acyloxyalkyl, acylaminoalkyl, N-diacyl-iminoalkyl groups, alkylaminocarbonyl, oxacycloalkyl, oxacycloalkenyl, organosilane and organosiloxane groups and any of the above groups substituted with a zwitterionic group Z, a hydroxyl group or an isocyanate group; R?1 and R2¿ are individually selected from hydrogen and C¿1?-C12 alkyl groups; and at least one of groups R, R?3, and R4¿ contain an organosiloxane group Y and/or an organosilane group U. The invention additionally provides processes for the production of such an adduct, polymers formed therefrom, coating processes and compositions comprising an adduct or polymers produced therefrom.
摘要:
An implant having a coating comprising a polymer matrix is swollen in a pharmaceutical solution whereby pharmaceutically active compound is imbibed into the polymer matrix. When the product is implanted, release of the pharmaceutically active compound from the coating takes place. The polymer is preferably formed from ethylenically unsaturated monomers including a zwitterionic monomer, most preferably 2-methacryloyloxyethyl-2'-trimethylammoniumethylphosphate inner salt. The monomers from which the polymer is formed may further include surface binding monomers, such as hydrophobic group containing monomers, and crosslinkable monomers, the content of which may be used to control the swellability. Preferably the implant is a stent and the coating of polymer on the exterior wall surface is thicker than the coating of polymer on the interior surface. Release of the drug may be controlled by selection of comonomers. The implant is suitably a stent for use in the cardiovascular system.
摘要:
A polymer is formed of ethylenically unsaturated monomers including a zwitterionic monomer, an aromatic monomer and a cross-linking monomer. Preferably the crosslinking monomer includes at least one aromatic group containing compound and at least one aliphatic group containing compound. The polymer is water-swellable and a hydrogel has optical and mechanical properties rendering it suitable for use as an intraocular refractive device such as an intraocular lens.
摘要:
A method in which a mould is coated with a reactive polymer, a liquid curable composition is filled into the mould and cured under conditions such that the reactive polymer becomes covalently bonded to the cured bulk mould material at the interface. The reactive polymer has zwitterionic groups to confer improved biocompatibility on the moulded product. The reactive group on the reactive polymer is conveniently an ethylenically unsaturated group. The curable composition is suitably a radical polymerisable ethylenically unsaturated monomer mixture or a platinum-curable liquid silicone composition.
摘要:
A polyurethane reaction product of a di- or polyisocyanate and a diol or polyol having at least two hydroxyl groups capable of reacting with an isocyanate group and having the residue of at least one further hydroxyl group present in the form of a phosphorus acid ester group of formula (I), wherein n is 0 or 1, m is 2, 3, or 4 and each R independently is an alkyl group of 1 to 4 carbons optionally with a diol or polyol which does not contain a group of formula I is useful in biocompatible, particularly haemocompatible devices for use in methods of medical treatment.
摘要:
Un produit de réaction polyuréthane d'un di- ou polyisocyanate et d'un diol ou d'un polyol possédant au moins deux groupes hydroxyle susceptibles de réagir avec un groupe isocyanate et présentant le résidu d'au moins un autre groupe hydroxyle sous forme d'un groupe ester d'acide phosphoreux de formule (I) où n vaut 0 ou 1, m vaut 2, 3 ou 4 et chaque R séparément est un groupe alkyl de 1 à 4 carbones avec éventuellement un diol ou un polyol ne contenant pas un groupe de formule (I), est utile dans des appareils biocompatibles, et notamment hémocompatibles utilisés dans les traitements médicaux.